Private Banking|Professional Solutions|Investment Management|Investment Banking|About us
Contact
Login
  • Solutions
  • Sectors
  • Careers
Oct 2016
probiodrug
Sole Global Coordinator & Joint Bookrunner
€ 14.9 million
Accelerated Bookbuild Offering

Probiodrug

Probiodrug is a biopharmaceutical company dedicated to the research and development of novel therapeutic solutions to treat people with Alzheimer’s Disease.

  • Accelerated bookbuild offering amounting to €14.9m.
  • Proceeds will be used to finance clinical development of their lead product and to support exploration and development of additional business opportunities.
  • Kempen & Co acted as Sole Global Coordinator and Joint Bookrunner in the transaction.

Fully focused on your future

Private Banking
  • Offices
  • Entrepreneurs
  • Healthcare
  • Executives
  • Business professionals
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland

Professional Solutions
Investment Management
Investment Banking

© Van Lanschot Kempen NV 2024About usSecurity and fraud awarenessPrivacy & cookiesDisclaimer